Objective: It is aimed to characterize the true relationship of the cold ischemia time (CIT) with graft survival and with the principal post-transplantation events.
Introduction
It is a proven fact that renal transplantation improves the survival of patients with terminal renal failure compared to those who remain on dialysis. 1 This benefit provided by the graft makes that a prime target in the current scenario of the transplant is to optimize the survival results of the same. With this aim, the detailed study of these modifiable factors that affect the function of the transplanted kidney is of vital importance.
In this sense there is increasing evidence that the function of the transplanted organ may be affected in the early hours surrounding brain death, and even from the moment when the future donor is admitted to the Intensive Care Unit. 2, 3 Between these first moments and the time of the transplantation, the cold ischemia time (CIT) is a major modifiable factor that may affect graft survival. The extended CIT has traditionally been associated with worse functional outcomes, and for this reason, the nephrourological world's efforts in recent times have been directed towards an attempt to shorten it to the maximum. 4, 5 Besides, special interest has been placed on the fact that in certain populations of donors, such as elderly and with expanded criteria donors, the CIT could have a pernicious effect. Therefore, the efforts to shorten the ischemia times would have to be intensified in these cases. 6, 7 With this work we intend to analyze the true relation of the CIT with the graft survival and to study its effect on the major postsurgical events (acute rejection, delayed function and medical-surgical complications) from the perspective of a single center study. We will review the scientific literature also analyzing the results of other studies of these characteristics, as well as the major multicenter studies published to date to obtain overall conclusions.
In short, we will try to determine the interval of safe cold ischemia time for transplanted grafts, if possible looking for a hypothetical cut-off point that defines it.
Material and methods
We analyzed 419 transplants performed between 1994 and 2009. We excluded from them the living donor transplants (n = 12) and those with medical-surgical complications occurred during the first post-intervention month and that decisively influenced the evolution of the graft (n = 24). In 5 patients, we did not get the information from the CIT, so they were also excluded. The final group was of 378 transplants from cadaveric donors.
We analyzed in them the factors related to the CIT, its impact on the major postoperative medical and surgical complications and we assessed their influence on the graft survival. The CIT was defined as the time between the initial perfusion of the organ and the onset of the vascular suture during the surgical intervention.
The clinicopathological variables listed in Table 1 were obtained from the patient's medical history. Acute rejection was confirmed by biopsy, and before the improvement of the renal function after the administration of corticosteroids. The biopsies were classified into the following groups: normal, borderline rejection, and grade 1, 2, and 3 rejections. The number of rejections and the time to the first rejection were collected. The chronic rejection was also classified into two grades (according to Banff criteria). The delayed function was collected as a lack of renal function in the first week post-transplantation. In cases of predialysis patients, the delayed function was defined as the absence of decrease of the prior creatinine during the first week. The surgical complications were confirmed by ultrasound, computerized tomography, or surgical exploration. The standardized surgical technique is described in previous works. 8 In order to study the relation of the CIT as a continuous variable with the graft survival, we performed a univariate analysis according to the Cox regression model. Subsequently, we looked for the best cut-off point beyond which there are differences in the graft survival by sizing up making subgroups with the Kaplan---Meier method and the log-rank test.
So as to adjust according to heterogeneous distribution variables a stratum by stratum analysis was performed. The event for the study of the graft survival was the patient's entry into dialysis. The patients who died with functioning grafts have been treated as censused at the time of their death. The studies of homogeneity between groups were made by comparison of proportions with the Chi-square test for qualitative variables, and comparison of means using the Student's t-test for quantitative variables. The increased risk of acute rejection and delayed graft function, according to the CIT as a continuous variable, was studied by binary logistic regression, also looking for cut-off points by sizing up. In order to know which are the variables that are related in an independent way with the graft survival, a multivariate analysis was performed according to the Cox models. The normality of the variable ''cold ischemia time'' in hours was determined using the Kolmogorov---Smirnov and Shapiro---Wilk tests. A p value <0.05 was required to determine statistical significance.
All the statistical analyses were performed using the SPSS program (Statistical Product and Services Solutions, 15.0 version, SPSS Inc., Chicago, IL, USA).
Results
The mean and median follow-up of the whole group (n = 378) was 77.8 months (±51 SD) and 73.8 months (range = 85.1), respectively. The mean CIT time of the entire group was 14.8 h (±5.1 SD) and the median was 14.4 h (range = 28.5). The cold ischemia time variable followed a normal distribution. Other clinicopathological variables are shown in Table 1 .
Analysis of graft survival
The graft survival of the entire group at 5 years was 89.5%. Of the 284 recipients with cold ischemia time lower than or equal to 18 h, 38 lost the graft at the end of the study (86.6% 5-year survival). In the group of recipients with cold ischemia time over 18 h (n = 94), there were 31 events (67% 5-year survival). The univariate analysis reveals that the cold ischemia time is not related to the graft survival as a continuous variable (OR = 1.04; 95% CI: 0.9---1.08; p > 0.05).
In the actuarial study we found differences in the graft 3 and 5-year survival starting at 18 h, with better results in the group with less than 18 h of ischemia. The 3 and 5-year survival was 96% (95% CI; 95---97%) and 91% (95% CI; 90---92%) vs. 89% (95% CI; 86---92%) and 84% (95% CI 80---88%), respectively ( Fig. 1) .
A study of homogeneity was conducted between these two groups (CIT <18 vs CIT >18), resulting comparable with respect to cardiovascular risk factors listed in Table 1 . We only find differences in donor age, which was higher in the group with a CIT >18 h (51.5 years ± 16.2 vs. 46.2 years ± 18.6; p = 0.014). In fact, in the group of grafts from donors older than 60, 38 (32.8%) had a CIT >18 h, whereas in the group of donors under 60, 56 (21.4%) had these ischemia times (p = 0.018). When performing the survival analysis anew, adjusting for the donor age variable, the CIT does not affect the graft survival (p > 0.05).
In short, the CIT is related to the graft survival with its cut-off point within the 18 h, but it is not related to the same as a continuous or independent variable. Furthermore, when adjusting for donor age, the significance is lost. In this series, the variables with independent influence on the graft survival were acute rejection, delayed function, and immediate surgical reintervention (OR 1.7, 3.5, and 2.5, respectively).
Factors associated with cold ischemia time
When studying the relations of the CIT with the deferred function, we observe that after 11 h there is an increased risk for it to take place (OR = 2.8; 95% CI 1.2---6.5; p = 0.012).
We notice a clear increase in the incidence of deferred function in the group with more than 11 h of ischemia (59/20.3% vs. 9/10.3%; p < 0.034). Besides, for each hour of ischemia, a 10% increase in the risk of delayed function is produced (OR = 1.1, 95% CI: 1.05---1.15; p < 0.001). As for rejection, the results indicate that it is again after 18 h when there is an increased risk of occurrence of the same (OR = 1.7, 95% CI 1.08---2.7; p = 0.021). In graft recipients with more than 18 h of cold ischemia there is an increased incidence of the acute episode (118/41.5% vs. 52/55.3%; p = 0.02) and of chronic rejection (21/22.6% vs. 33/11.6%; p = 0.009), and less time to the first rejection episode (72.6 days ± 137 vs. 272.2 days ± 614.8; p = 0.023). In contrast, the CIT variable in hours did not relate as a continuous variable to the acute rejection (OR = 1.03; 95% CI 0.9---1.07; p > 0.05).
Time (Months)
The CIT impact on the acute rejection and the delayed function is reflected in the findings of the imaging tests performed in the first 24 h after transplantation. The immediate resistivity rates (43/46.2% vs. 60/21.3%; p < 0.001) and the immediate scintigraphic vascular phase (19/20.2% vs. 16/5.7%, p < 0.001) were more frequently altered in the group with more than 18 h. For the rest of posttransplantation events, such as surgical complications (vascular, parietal, or urological) or hospital admissions, the cold ischemia time did not appear to increase its incidence (p > 0.05).
Discussion
In recent times the possible role of the CIT has been postulated as an essential factor in the ischemia-reperfusion damage, an influential phenomenon in renal graft survival. The degree of this endothelial injury would relate to the prior characteristics of the graft at the time of vascular flow being restored, and it would be helped by an extended CIT, initiating a process of immunological activation that could eventually trigger renal failure. 9 A close relation of the CIT with the delayed function and with the acute rejection, along with two factors clearly influential in the future of the graft, has also been described.
10---13
Intuitively, we assume that prolonged periods of ischemia have a negative effect on renal function, but the fact is that its impact as an independent factor on the renal graft survival is not yet clear. At the same time, the question arises of where the cut-off point beyond which the survival of the graft begins to worsen is, and whether there will be benefits when transplanting grafts drastically shortening the CIT.
With this work we tried to clarify the true relation of the CIT with the graft survival and the different events of the post-transplantation. For this purpose, we have analyzed the major studies published in this field, comparing their results with ours.
Single center studies allow for the use of the donors' and recipients' data in a more detailed way, and they have the advantage that the study population is more homogeneous in terms of immunosuppressive treatment and clinical practice. The results regarding the relation of the CIT with the graft survival in this type of studies published to date are contradictory.
While some works find no differences in the graft survival at 5 years, 11, 13, 14 others state the opposite. Among the latter ones, Roodnat et al., 15 maintain that the CIT independently influences the graft survival as a continuous variable without acting through other variables. They also noticed that this relation was valid only for the immediate posttransplantation, during the first week, and that this effect was lost over time. Other works set cut-off points between 21 and 24 h after which the results of the graft survival decrease significantly. 16, 17 Although some multivariate analysis include cold ischemia as a significant variable, 16, 17 the evidence seems to suggests that the CIT is not independently related to the graft survival, but it does so through the delayed function. 13, 14 Most studies claim that the CIT is related to PD in the early hours. 13,14,16---18 In the case of acute rejection the studies are more heterogeneous, but it seems that there is an increase in its incidence from longer ischemia times, between 18 and 24 h. 17 From the multicenter studies we obtain more global and more powerful information that intends to clarify the controversies raised by single center studies. Su et al. studied 33,443 dead donor transplants from the database of the United Network of Organ Sharing (UNOS) and the United States Renal Data System (USRDS). 19 They found an association between the CIT and the actuarial graft survival, establishing the cut-off point at 36 h. When forming groups (9---16 h, 17---24 h, 25---36 h, 37---48 h and >48 h) they noticed an increased risk of graft loss as the ischemia hours increased. Ojo et al. analyzed 37,216 first cadaveric donor transplants performed between 1985 and 1992 from the USRDS. 20 The CIT was associated in this study with the delayed function as a continuous variable, with an increased risk of 23% for each increase of 6 h of the same. When comparing the influence of the CIT on the graft survival at 5 years, it did not differ between the groups with <12 h and 13---24 h (60 vs 61%). However, by setting the cut-off point at 12 h and comparing it with the rest of the group, they found significant differences (52 vs 61%, p < 0.001). This finding suggests that probably very long CITs directly and independently relate to the graft survival.
Another multicenter study that indirectly studies the impact of the CIT on the graft survival is the Eurotransplant Senior Program (ESP). 21 This kidney transplant program, started in 1999, involves the use of kidneys obtained from donors older than 65 years transplanted into recipients older than 65 years. In this case, the CIT is prioritized as opposed to the Eurotransplant Kidney Allocation System (ETKAS) program that prioritizes HLA-compatibility. As we observe, this study does not directly analyze the impact of the CIT on the graft survival, but it compares a group that emphasizes shorter ischemic times compared to another one in which the HLA-compatibility is prioritized. 22 In this case, the ESP group was associated with a lower CIT and a lower incidence of delayed function but with a 5---10% higher acute rejection rate. Regarding the graft survival at 5 years, no differences were found.
In the Collaborative Transplant Study (CTS), during the period 1986---1996, Opelz et al. conducted a multicenter study analyzing 25,123 transplants in which they assessed the impact of the CIT on the graft survival. 23 In this case, the CIT did not prove to be an independent factor influencing the graft survival. The HLA-compatibility, the rejection and the delayed function were the best predictors of the graft survival. Paradoxically, the group with a CIT of 0---6 h did not obtain the best survival results. In fact, the graft survival in this group was lower than in the groups with ischemia times of 25---36 h and between 37 and 48. This was associated with the fact that many of the patients with CIT <6 h had been transplanted without considering strict criteria of HLA-compatibility precisely to favor a short CIT. In the second period of the CTS, between 1999 and 2005, 91,674 transplants were included and 195 centers from 26 nations took part. 24 When assessing the impact of the CIT on the graft survival no differences were found until 18 h later. It was also noticed that a short CIT (<7 h, n = 2310) is not enough to match results of unrelated living donor (n = 1397). In this work, the CIT did not influence the effect of the HLA-compatibility either.
Traditionally, the belief that in those donors over 65 years the extended CIT was especially harmful regarding the graft functional outcomes has been maintained. 25 By studying 5997 patients over 65 years in this group worse survival than with donors younger than 65 years was noticed, and no particular influence of the CIT was observed. The influence of the short ischemia time was the same as in the group younger than 45 years, and it was the donor's own age which determined worse outcomes in the graft survival. In 44,264 grafts from suboptimal donors worse survival was observed when compared to normal grafts, but no special influence of the CIT was observed either.
In short, the relationship between the graft survival and the CIT seems clear. 19, 20, 24 Although the CIT is not related as a continuous variable to the graft survival, it is clear that there are cut-off points (between 12 and 18 h) from which this decreases significantly. In addition, the multicenter studies show that the CIT is not related independently to the graft survival. It is probably related through the increased incidence of the delayed function which is associated with it. 20 The study that we now present offers similar results and sets a cut-off point at 18 h, showing that there are also other more important variables in terms of impact on the survival of the transplanted kidney. Specifically, the donor's own age and the immunological factors seem to play a role of greater importance. 24 The CIT does not seem such a good indicator of the ischemia-reperfusion damage as it was initially thought. However, it is fair to say that probably very long cold ischemia times would indeed relate directly and independently to the graft survival. Therefore, in those countries or regions where because of the type of organ allocation policy it is more costly to achieve short cold ischemia times, this variable can magnify its impact on the graft function and be within the range of factors that determine its survival. In short, the CIT interval below 18 h, which most groups in our environment face, seems safe for the graft survival.
